In the latest session, Purple Biotech Ltd ADR (NASDAQ: PPBT) closed at $0.67 up 9.66% from its previous closing price of $0.61. In other words, the price has increased by $+0.0500 from its previous closing price. On the day, 98816 shares were traded. PPBT stock price reached its highest trading level at $0.6700 during the session, while it also had its lowest trading level at $0.6200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
For a deeper understanding of Purple Biotech Ltd ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.20 and its Current Ratio is at 2.20. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PPBT now has a Market Capitalization of 17.60M and an Enterprise Value of 2.54M.
Stock Price History:
Over the past 52 weeks, PPBT has reached a high of $2.16, while it has fallen to a 52-week low of $0.53. The 50-Day Moving Average of the stock is 0.7151, while the 200-Day Moving Average is calculated to be 1.0449.
Shares Statistics:
For the past three months, PPBT has traded an average of 100.46K shares per day and 86.59k over the past ten days. A total of 25.94M shares are outstanding, with a floating share count of 25.75M. Insiders hold about 0.75% of the company’s shares, while institutions hold 11.01% stake in the company. Shares short for PPBT as of Mar 15, 2024 were 223k with a Short Ratio of 2.22, compared to 315.36k on Feb 15, 2024.
Earnings Estimates
There are 3 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.19 for the current quarter, with a high estimate of -$0.17 and a low estimate of -$0.21, while EPS last year was -$0.33. The consensus estimate for the next quarter is -$0.19, with high estimates of -$0.15 and low estimates of -$0.23.
Analysts are recommending an EPS of between -$0.9 and -$0.93 for the fiscal current year, implying an average EPS of -$0.91. EPS for the following year is -$0.63, with 3 analysts recommending between -$0.46 and -$0.96.
